OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ANALYSIS OF IMMUNE ESCAPE VARIANTS FROM ANTIBODY-BASED THERAPEUTICS AGAINST COVID-19
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Showing 12 citing articles:
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge
Daniele Focosi, Rodrigo Quiroga, Scott A. McConnell, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2264-2264
Open Access | Times Cited: 123
Daniele Focosi, Rodrigo Quiroga, Scott A. McConnell, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2264-2264
Open Access | Times Cited: 123
Recombination in Coronaviruses, with a Focus on SARS-CoV-2
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 99
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 99
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 88
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 88
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
Daniele Focosi, Marco Tuccori
Pathogens (2022) Vol. 11, Iss. 8, pp. 823-823
Open Access | Times Cited: 21
Daniele Focosi, Marco Tuccori
Pathogens (2022) Vol. 11, Iss. 8, pp. 823-823
Open Access | Times Cited: 21
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance
Daniele Focosi
Viruses (2023) Vol. 15, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 9
Daniele Focosi
Viruses (2023) Vol. 15, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 9
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S. Piepenbrink, Jun‐Gyu Park, Ashlesha Desphande, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Michael S. Piepenbrink, Jun‐Gyu Park, Ashlesha Desphande, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents
Jacek Plichta, Piotr Kuna, Michał Panek
COVID (2022) Vol. 2, Iss. 5, pp. 599-620
Open Access | Times Cited: 9
Jacek Plichta, Piotr Kuna, Michał Panek
COVID (2022) Vol. 2, Iss. 5, pp. 599-620
Open Access | Times Cited: 9
Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations
Gabriel Cia, Fabrizio Pucci, Marianne Rooman
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2078-2078
Open Access | Times Cited: 7
Gabriel Cia, Fabrizio Pucci, Marianne Rooman
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2078-2078
Open Access | Times Cited: 7
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients
Cesare Ernesto Maria Gruber, Fabio Giovanni Tucci, Martina Rueca, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1538-1538
Open Access | Times Cited: 1
Cesare Ernesto Maria Gruber, Fabio Giovanni Tucci, Martina Rueca, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1538-1538
Open Access | Times Cited: 1
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape
Daniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2488-2488
Open Access
Daniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2488-2488
Open Access
